# Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication

> **NCT03092206** · PHASE1 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 30 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** F/TAF
- **DRUG:** E/C/F/TAF
- **DRUG:** R/F/TAF

## Key facts

- **NCT ID:** NCT03092206
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-18
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-07-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092206, "Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03092206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*